Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
H.R. 1492 - EPIC Act: Provisions regarding harmonizing small and large molecule period in the Inflation Reduction Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2025 · second_quarter · Q2
H.R. 1492 - EPIC Act: Provisions regarding harmonizing small and large molecule period in the Inflation Reduction Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2025 · first_quarter · Q1
Source: Senate LDA
H.R. 1492 - EPIC Act: Provisions regarding harmonizing small and large molecule period in the Inflation Reduction Act.
American Innovation and R&D Competitiveness Act of 2025
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
H.R. 1990 - American Innovation and R&D Competitiveness Act: Provisions regarding Section 174 research and development tax credit amortization.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
Build It in America Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938: Build it in America Act - Provisions regarding research and development tax amortization. S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax amortization.
Build It in America Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938/S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax credit amortization.
Build It in America Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938: Build it in America Act - Provisions regarding research and development tax credit amortization. S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax credit amortization.
Build It in America Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938: Build it in America Act - Provisions regarding research and development tax amortization. S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax amortization.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception. H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program - Provisions regarding reforms to the Inflation Reduction Act (IRA) MFP negotiation process.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception. H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program - Provisions regarding reforms to the Inflation Reduction Act (IRA) MFP negotiation process. Part D 6 protected classes policy. Medicaid Drug Rebate Program Rule - Provisions regarding "stacking" of rebates and discounts.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception. H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program - Provisions regarding reforms to the Inflation Reduction Act (IRA). Part D 6 protected classes policy. Medicaid Drug Rebate Program Rule - Provisions regarding "stacking" of rebates and discounts.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception. H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program - Provisions regarding reforms to the Inflation Reduction Act (IRA). Part D 6 protected classes policy. Medicaid Drug Rebate Program Rule - Provisions regarding "stacking" of rebates and discounts.
Pharmacy Benefit Manager Reform Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
Pharmacy Benefit Manager Reform Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
Pharmacy Benefit Manager Reform Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
Pharmacy Benefit Manager Reform Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
Modernizing and Ensuring PBM Accountability Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
Modernizing and Ensuring PBM Accountability Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
Modernizing and Ensuring PBM Accountability Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
Modernizing and Ensuring PBM Accountability Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
American Innovation and Jobs Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938: Build it in America Act - Provisions regarding research and development tax amortization. S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax amortization.
American Innovation and Jobs Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938: Build it in America Act - Provisions regarding research and development tax credit amortization. S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax credit amortization.
American Innovation and Jobs Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938: Build it in America Act - Provisions regarding research and development tax amortization. S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax amortization.
American Innovation and Jobs Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938/S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax credit amortization.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - provisions regarding regulation of pharmacy benefit managers.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - provisions regarding regulation of pharmacy benefit managers.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers.
Build It in America Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938/S. 866: American Innovation and Jobs Act - provisions regarding research and development tax credit amortization.
Build It in America Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938/S. 866: American Innovation and Jobs Act - provisions regarding research and development tax credit amortization.
Build It in America Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938/S. 866: American Innovation and Jobs Act - provisions regarding research and development tax credit amortization.
Pharmacy Benefit Manager Reform Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers.
Pharmacy Benefit Manager Reform Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - provisions regarding regulation of pharmacy benefit managers.
Pharmacy Benefit Manager Reform Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - provisions regarding regulation of pharmacy benefit managers.
Modernizing and Ensuring PBM Accountability Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - provisions regarding regulation of pharmacy benefit managers.
Modernizing and Ensuring PBM Accountability Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - provisions regarding regulation of pharmacy benefit managers.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - provisions regarding regulation of pharmacy benefit managers.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - provisions regarding regulation of pharmacy benefit managers.
American Innovation and Jobs Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938/S. 866: American Innovation and Jobs Act - provisions regarding research and development tax credit amortization.
American Innovation and Jobs Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938/S. 866: American Innovation and Jobs Act - provisions regarding research and development tax credit amortization.
American Innovation and Jobs Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
HR 3938/S. 866: American Innovation and Jobs Act - provisions regarding research and development tax credit amortization.
Inflation Reduction Act of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
Inflation Reduction Act, HR 5376; Omnibus Mental Health Legislation, HR 7666
Inflation Reduction Act of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
Inflation Reduction Act, HR 5376; Omnibus Mental Health Legislation, HR 7666
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
Omnibus Mental Health Legislation, HR 7666
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
Omnibus Mental Health Legislation, HR 7666, Medicare Part D Reform
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
Omnibus Mental Health Legislation, HR 7666, Medicare Part D Reform
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
PDUFA VII, Drug Importation, HR 7667, Omnibus Mental Health Legislation, HR 7666
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
PDUFA VII, Drug Importation, HR 7667, Omnibus Mental Health Legislation, HR 7666
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
Omnibus Mental Health Legislation, HR 7666; PDUFA VII, Drug Importation, HR 7667
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
Inflation Reduction Act, HR 5376; Omnibus Mental Health Legislation, HR 7666
Restoring Hope for Mental Health and Well-Being Act of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
Inflation Reduction Act, HR 5376; Omnibus Mental Health Legislation, HR 7666
Food and Drug Amendments of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
PDUFA VII, Drug Importation, HR 7667, Omnibus Mental Health Legislation, HR 7666
Food and Drug Amendments of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
PDUFA VII, Drug Importation, HR 7667, Omnibus Mental Health Legislation, HR 7666
Food and Drug Amendments of 2022
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
Omnibus Mental Health Legislation, HR 7666; PDUFA VII, Drug Importation, HR 7667
Neuroscience Center of Excellence Act of 2021
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
PDUFA VII; S 3427 FDA NCOE Authorization
American Innovation and Jobs Act
Client: INTRA-CELLULAR THERAPIES, INC. · Firm: INTRA-CELLULAR THERAPIES, INC.
S 749, American Jobs and Innovation Act
H.R. 1492 - EPIC Act: Provisions regarding harmonizing small and large molecule period in the Inflation Reduction Act.
H.R. 1990 - American Innovation and R&D Competitiveness Act: Provisions regarding Section 174 research and development tax credit amortization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2024 · fourth_quarter · Q4
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception. H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program - Provisions regarding reforms to the Inflation Reduction Act (IRA) MFP negotiation process.
HR 3938: Build it in America Act - Provisions regarding research and development tax credit amortization. S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax credit amortization.
S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2024 · third_quarter · Q3
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception. H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program - Provisions regarding reforms to the Inflation Reduction Act (IRA) MFP negotiation process. Part D 6 protected classes policy. Medicaid Drug Rebate Program Rule - Provisions regarding "stacking" of rebates and discounts.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
HR 3938: Build it in America Act - Provisions regarding research and development tax amortization. S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax amortization.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2024 · second_quarter · Q2
HR 3938: Build it in America Act - Provisions regarding research and development tax amortization. S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax amortization.
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception. H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program - Provisions regarding reforms to the Inflation Reduction Act (IRA). Part D 6 protected classes policy. Medicaid Drug Rebate Program Rule - Provisions regarding "stacking" of rebates and discounts.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2024 · first_quarter · Q1
HR 3938/S. 866: American Innovation and Jobs Act - Provisions regarding research and development tax credit amortization.
HR 2630/S. 652: Safe Step Act - Provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - Provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - Provisions regarding regulation of pharmacy benefit managers.
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception. H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program - Provisions regarding reforms to the Inflation Reduction Act (IRA). Part D 6 protected classes policy. Medicaid Drug Rebate Program Rule - Provisions regarding "stacking" of rebates and discounts.
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2023 · fourth_quarter · Q4
HR 3938/S. 866: American Innovation and Jobs Act - provisions regarding research and development tax credit amortization.
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception; Part D6 protected classes policy.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - provisions regarding regulation of pharmacy benefit managers.
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2023 · third_quarter · Q3
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception; Part D6 protected classes resolution.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers. S. 2973: Modernizing and Ensuring PBM Accountability Act - provisions regarding regulation of pharmacy benefit managers.
HR 3938/S. 866: American Innovation and Jobs Act - provisions regarding research and development tax credit amortization.
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2023 · second_quarter · Q2
HR 3938/S. 866: American Innovation and Jobs Act - provisions regarding research and development tax credit amortization.
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers.
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception; Part D6 protected classes resolution.
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2023 · first_quarter · 1A
Inflation Reduction Act (IRA) implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2023 · first_quarter · Q1
Inflation Reduction Act (IRA) implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2022 · fourth_quarter · Q4
Inflation Reduction Act, HR 5376; Omnibus Mental Health Legislation, HR 7666
Omnibus Mental Health Legislation, HR 7666
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2022 · second_quarter · 2A
PDUFA VII, Drug Importation, HR 7667, Omnibus Mental Health Legislation, HR 7666
Omnibus Mental Health Legislation, HR 7666, Medicare Part D Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2022 · third_quarter · Q3
S 749, American Jobs and Innovation Act
Inflation Reduction Act, HR 5376; Omnibus Mental Health Legislation, HR 7666
Omnibus Mental Health Legislation, HR 7666; PDUFA VII, Drug Importation, HR 7667
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2022 · second_quarter · Q2
PDUFA VII, Drug Importation, HR 7667, Omnibus Mental Health Legislation, HR 7666
Omnibus Mental Health Legislation, HR 7666, Medicare Part D Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2022 · first_quarter · Q1
PDUFA VII; S 3427 FDA NCOE Authorization
Senate Finance Committee - Mental Health Omnibus Bill; Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTRA-CELLULAR THERAPIES, INC. via INTRA-CELLULAR THERAPIES, INC.
2022 · first_quarter · RR
Education regarding ITCI products; access to mental health issues; mental health delivery system; Part D benefit issues
Education regarding ITCI products; access to mental health issues; mental health delivery system; Part D benefit issues
Education regarding ITCI products; access to mental health issues; mental health delivery system; Part D benefit issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE